Showing 1-10 of 17 "Other"

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Beatriz Efron

Phone: 713.363.8890

The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). ... Read more >

Status: Enrolling

Investigator: Alan Lumsden

Study Coordinator: Rachel Kronman-Gross

Phone: 713.441.6539

Objective is to actively gather information on the use of CorMatrix ECM for vascular repair in the reconstruction of the femoral artery. ... Read more >

Status: Enrolling

Investigator: David Baskin

Study Coordinator: Julie Baskin

Phone: 713.441.3800

The objective of this study is to evaluate the safety and efficacy of FS VH S/D 500 s-apr for use as an adjunct to sutured dural repair in cranial surgery (NCT02891070). ... Read more >

Status: Enrolling

Investigator: Richard Klucznik

Study Coordinator: Bhavin Shah

Phone: 832.279.5111

The primary objective of this study is to gather post market data on the Penumbra SMART Coil™ System in the treatment of intracranial aneurysms and other malformations ... Read more >

Status: Enrolling

Investigator: Danielle Antosh

Study Coordinator: Alice Pavlak

Phone: 713..44.1.3246

This randomized, double-blind, placebo-controlled, multi-center, confirmatory study will evaluate the efficacy and safety of Cook MyoSite Incorporated Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR) compared to a placebo ... Read more >

Status: Active

Investigator: Rose Khavari

Study Coordinator: Rashmi Pande

Phone: 716.289.6679

The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units [U] and 800 U), compared to placebo in reducing urinary incontinence (UI) in adult subjects treated fo ... Read more >

Status: Enrolling

Investigator: Charudatta Bavare

Study Coordinator: Kim Donlon

Phone: 713.441.9394

To study the safety and efficacy of drug coated stents for the treatment of venous occlusions and stenoses in the lower extremity. The use of the device for the treatment of peripheral arterial disease is approved by the FDA, however, the use of ... Read more >

Status: Enrolling

Investigator: Jean Bismuth

Study Coordinator: Kim Donlon

Phone: 713.441.9394

This study is a prospective, multicenter, non-randomized single-arm study to assess the feasibility of the treatment of DeBakey Type I/II aortic dissections with the GORE® TAG® Thoracic Branch Endoprosthesis system. ... Read more >

Status: Open Not Enrolling

Investigator: Eric Peden

Study Coordinator: Kim Donlon

Phone: 713.441.9394

This trial will evaluate the safety and efficacy of concentrated bone marrow aspirate (cBMA) to prevent or delay major amputation and/or death in subjects with critical limb ischemia (CLI) due to severe peripheral arterial disease (PAD). ... Read more >

Status: Enrolling

Investigator: David Baskin

Study Coordinator: Julie Baskin

Phone: 713.441.3800

ICT-107 consists of dendritic cells, prepared from autologous mononuclear cells that are pulsed with six synthetic peptides that were derived from tumor associated antigens (TAA) present on glioblastoma tumor cells. This is a Phase 3 study to ev ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Beatriz Efron

Phone: 713.363.8890

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part ... Read more >

Status: Open Not Enrolling

Investigator: Eric Peden

Study Coordinator: Kim Donlon

Phone: 713.441.9394

This research study is designed to assess the safety and effectiveness of an experimental drug called PRT-201 in patients who have chronic kidney disease and who are undergoing surgery to create a new access point to their bloodstream for hemodi ... Read more >

Status: Open Not Enrolling

Investigator: Mary Ruppe

Study Coordinator: Romeo Parada

Phone: 713.443.7005

UX023-CL303 is a phase 3 multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of KRN23 in adult subjects with XLH. Approximately 120 subjects with a diagnosis of XLH supported by clinical and bioche ... Read more >

Status: Enrolling

Investigator: Colin Barker

Study Coordinator: Amber Jacobs

Phone: 713.441.3905

The purpose of this study is to determine the incidence and predictors of high degree or complete atrioventricular block (AVB) (paroxysmal or persistent) in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transca ... Read more >

Status: Enrolling

Investigator: Joshua Swan

Study Coordinator: Isioma Agboli

Phone: 713.447.368

Ventilated ICU patients frequently have sepsis and the majority have delirium, a form of brain dysfunction that is an independent predictor of increased risk of dying, length of stay, costs, and prolonged cognitive impairment in survivors. Unive ... Read more >

Status: Open Not Enrolling

Investigator: Mary Ruppe

Study Coordinator: Romeo Parada

Phone: 713.443.7005

UX023T-CL201 is an, open-label, Phase 2 study. The study will be conducted in adults aged 18 years or older with TIO or ENS whose tumor/skin lesion is inoperable to assess the efficacy and safety of KRN23 administered via subcutaneous injections ... Read more >

Status: Open Not Enrolling

Investigator: Mary Ruppe

Study Coordinator: Romeo Parada

Phone: 713.443.7005

The primary purpose of this study is to assess the safety and efficacy of repeated subcutaneous (SC) injections of KRN23 in adult subjects with X-Linked Hypophosphatemia (XLH). A Bone Substudy will evaluate the effects of single-blind KRN23 vers ... Read more >